Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Features

Keay Nakae, CFA, senior research analyst at Chardan
Feature Story
Skin Microbiome Medicines in Development to Treat Skin Diseases: Discussion with Keay Nakae, CFA
09/28/2021
The microbiome harnesses great potential, both in disease progression and in therapeutic advances. Keay Nakae, CFA, shares knowledge regarding emerging microbiome treatment trends for dermatologic diseases.
The microbiome harnesses great potential, both in disease progression and in therapeutic advances. Keay Nakae, CFA, shares knowledge regarding emerging microbiome treatment trends for dermatologic diseases.
The microbiome harnesses great...
09/28/2021
The Dermatologist
Feature Story
Using Ancillary Tests in the Diagnosis of Melanoma
09/15/2021
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be...
09/15/2021
The Dermatologist
Feature Story
Topical JAK Inhibitor Offers Promise for Two Skin Diseases
09/15/2021
A number of emerging therapies involving the JAK-STAT pathway are in the pipeline for immune-mediated inflammatory diseases. One particular Janus kinase inhibitor shows potential for atopic dermatitis and vitiligo.
A number of emerging therapies involving the JAK-STAT pathway are in the pipeline for immune-mediated inflammatory diseases. One particular Janus kinase inhibitor shows potential for atopic dermatitis and vitiligo.
A number of emerging therapies...
09/15/2021
The Dermatologist
Feature Story
Mohs Surgery in a Post-COVID World: Improving Patient Outcomes in 2021
08/16/2021
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published...
08/16/2021
The Dermatologist
Q&As
CPC: Advice From a Dermatologist-Dermatopathologist
08/16/2021
Clinicopathologic correlation (CPC) depends on alignment between a clinical diagnosis and the histopathologic findings of a biopsy. Dr Kiran Motaparthi shares how to improve CPC and the communication between dermatologist and...
Clinicopathologic correlation (CPC) depends on alignment between a clinical diagnosis and the histopathologic findings of a biopsy. Dr Kiran Motaparthi shares how to improve CPC and the communication between dermatologist and...
Clinicopathologic correlation...
08/16/2021
The Dermatologist
Feature Story
Treating Papulopustular Rosacea With Oral Sarecycline
07/16/2021
With dermatologists continuing to research therapeutic agents in treating papulopustular rosacea, Dr James Q. Del Rosso offers...
With dermatologists continuing to research therapeutic agents in treating papulopustular rosacea, Dr James Q. Del Rosso offers...
With dermatologists continuing...
07/16/2021
The Dermatologist
Feature Story
Recognizing the Impact of Diseases in Skin of Color
07/16/2021
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker...
07/16/2021
The Dermatologist
Feature Story
Puzzling Erythematous Patches Managed with Anakinra
07/11/2021
A patient presented with a puzzling rash of the abdomen following pharyngitis, rhinorrhea, cough, and worsening dyspnea. The authors report the diagnosis and treatment of a rare multisystemic disorder, adult-onset Still’s disease.
A patient presented with a puzzling rash of the abdomen following pharyngitis, rhinorrhea, cough, and worsening dyspnea. The authors report the diagnosis and treatment of a rare multisystemic disorder, adult-onset Still’s disease.
A patient presented with a...
07/11/2021
The Dermatologist
Feature Story
Redefining Our Risk Tolerance During “Reentry” in the COVID-19 Era
06/17/2021
Another shift from the pandemic was personal definitions of risk tolerance in terms of health safety. It is once again time to consider redefining what risk tolerance means as public health intiatives move us past the pandemic.
Another shift from the pandemic was personal definitions of risk tolerance in terms of health safety. It is once again time to consider redefining what risk tolerance means as public health intiatives move us past the pandemic.
Another shift from the pandemic...
06/17/2021
The Dermatologist
Dr Jill Waibel on Laser Assisted Delivery for the Treatment of Scars
Conference Coverage
Dr Jill Waibel on Laser Assisted Delivery for the Treatment of Scars
04/23/2021
During the "Scars: What Have We Learned And Where Are We Going?" session at AAD VMX 2021, Jill S. Waibel, MD, FAAD, discussed laser-assisted delivery for the treatment of scars.
During the "Scars: What Have We Learned And Where Are We Going?" session at AAD VMX 2021, Jill S. Waibel, MD, FAAD, discussed laser-assisted delivery for the treatment of scars.
During the "Scars: What Have We...
04/23/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

October 2024
Volume 32
Issue 7
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

New Recommendations for Detecting Mycobacterium Haemophilum in Tattooed Patients
08/16/2011
In November 2009, two cases of mycobacterium haemophilum – one confirmed, one suspected – were reported in Seattle. Both cases resulted after the individuals, who were otherwise immunocompetent, had gotten tattoos at the same tattoo parlor....
In November 2009, two cases of mycobacterium haemophilum – one confirmed, one suspected – were reported in Seattle. Both cases resulted after the individuals, who were otherwise immunocompetent, had gotten tattoos at the same tattoo parlor....
In November 2009, two cases of...
08/16/2011
The Dermatologist
News
Rosacea may be associated with development of glioma
02/04/2016
Danish researchers have linked the common facial skin disorder rosacea to the most frequent type of primary brain tumor in adults.
Danish researchers have linked the common facial skin disorder rosacea to the most frequent type of primary brain tumor in adults.
Danish researchers have linked...
02/04/2016
The Dermatologist
Ultraviolet Radiation: A Hazard to Children and Adolescents
03/04/2011
The following Policy Statement from the American Academy of Pediatrics was issued by its Council on Environmental Health and Section on Dermatology:
The following Policy Statement from the American Academy of Pediatrics was issued by its Council on Environmental Health and Section on Dermatology:
The following Policy Statement...
03/04/2011
The Dermatologist
Case Report and Brief Review
What is the Cause of this 5-Year-Old’s Itchy, Scaly, Pink Plaques?
12/18/2015
A 5-year-old girl presented with a 3-week history of multiple discrete, pink, scaly plaques. The plaques were ovoid, ranged from 0.5 to 3 cm in diameter, and were slightly raised, blanchable, and pruritic.
A 5-year-old girl presented with a 3-week history of multiple discrete, pink, scaly plaques. The plaques were ovoid, ranged from 0.5 to 3 cm in diameter, and were slightly raised, blanchable, and pruritic.
A 5-year-old girl presented with...
12/18/2015
The Dermatologist
Morria Biopharmaceuticals Begins Phase II Study of MRX6 for Contact Dermatitis
05/13/2010
Morria Biopharmaceuticals, Plc, has initiated a Phase II clinical trial on MRX6, its topical multi-functional anti inflammatory drug (MFAID). The double-blind, placebo-controlled study of up to 80 contact dermatitis patients will take place...
Morria Biopharmaceuticals, Plc, has initiated a Phase II clinical trial on MRX6, its topical multi-functional anti inflammatory drug (MFAID). The double-blind, placebo-controlled study of up to 80 contact dermatitis patients will take place...
Morria Biopharmaceuticals, Plc,...
05/13/2010
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement